CDEK
← All organizations

Cosmo Technologies Ltd

For profitContributed to NME

Also known as: COSMO TECHNOLOGIES | Cosmo Technologies Ltd

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 29, 2008

First marketed drug

Nov 16, 2018

First NDA

Nov 16, 2018

Last known activity

Mar 31, 2020

Timeline

2000s

  1. Jun 1, 2004

    Cosmo Technologies Ltd— Founded

2010s

  1. Nov 16, 2018

    rifamycin— NDA Organization

  2. Nov 16, 2018

    rifamycin— NDA Secondary Org

Drugs by trial phase (4 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (7)

Details

Founded
Dublin, IE Jun 1, 2004
First NDA
Nov 16, 2018
Last known activity
Mar 31, 2020

Designations held

  • Fast track
  • Priority review